文献速递烧伤创面修复

菠萝蛋白酶酶解清创与标准治疗在深度部分及全层烧伤中的系统综述与荟萃分析

Bromelain-based enzymatic debridement versus standard of care in deep partial- and full-thickness burns: A systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Burns · 2026-07-22

该系统综述与荟萃分析纳入5项随机对照试验,比较菠萝蛋白酶酶解清创(BBD)与标准治疗(SOC)在急性深度热烧伤中的效果。4项报告患者级结局的试验(n=336)显示,BBD显著减少需要手术切除的比例(RR 0.11,95%CI 0.06-0.23,I²=0%),绝对风险降低65%,需治疗人数1.5,并减少自体移植、缩短清创时间,12个月盲法瘢痕评估相当或更优。

要点

  • BBD显著降低深度烧伤患者需手术切除的风险(RR 0.11)。
  • BBD减少自体移植使用并缩短清创时间。
  • 12个月盲法瘢痕评估BBD不劣于或优于SOC。

核心结论

  • 随机证据表明,在早期治疗的清创适用、烧伤总面积有限的烧伤中,BBD减少手术和移植负担,不损害伤口闭合或长期重塑。

研究设计与样本

  • 系统综述与荟萃分析,纳入5项随机对照试验,比较BBD与SOC在急性深度热烧伤中的效果;主要结局为需要手术切除的比例,采用随机效应模型合并效应,预设敏感性分析评估一项伤口级试验,使用Cochrane RoB 2工具评估偏倚风险。

主要发现

  • 4项报告患者级结局的试验(n=336)中,BBD较SOC减少手术切除(RR 0.11;95%CI 0.06-0.23;I²=0%),绝对风险降低65%,需治疗人数1.5。
  • BBD与减少自体移植使用、缩短清创时间相关,12个月盲法瘢痕评估相当或改善。
  • 开放标签设计是潜在偏倚的主要来源;纳入伤口级试验的敏感性分析保持效应方向但异质性增加。

关键数值与推荐

  • BBD vs SOC:手术切除风险RR 0.11(95%CI 0.06-0.23;I²=0%),绝对风险降低65%,NNT 1.5(基于4项试验,n=336)。

临床怎么用

  • 对于早期治疗的清创适用、烧伤总面积有限的深度热烧伤,BBD可减少手术和移植负担,且不损害伤口闭合或长期重塑。

局限性

  • 开放标签设计是潜在偏倚的主要来源;未来试验需采用盲法手术终点判定、客观评估真皮保留及更广泛临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Management of debridement-eligible thermal burns requires accurate removal of devitalized tissue. Tangential excision remains limited by imprecise depth assessment beneath opaque eschar, risking unintended dermal sacrifice. Bromelain-based enzymatic debridement (BBD) has emerged as an alternative; however, its impact on patient-level surgical outcomes has not been rigorously quantified in randomized trials. METHODS: A systematic review and meta-analysis of randomized trials compared BBD with standard of care (SOC) in acute deep thermal burns. The primary outcome was the proportion requiring surgical excision. Random-effects models pooled effects. A prespecified sensitivity analysis evaluated a wound-level trial. Risk of bias was assessed using the Cochrane RoB 2 tool. RESULTS: Five randomized trials met criteria. Four reporting per-patient outcomes contributed to the primary meta-analysis (n = 336). BBD reduced surgical excision versus SOC (RR, 0.11; 95% CI, 0.06-0.23; I² = 0%), corresponding to an absolute risk reduction of 65% and a number needed to treat of 1.5. BBD was also associated with reduced autograft use, shorter time to debridement, and comparable or improved blinded scar assessments at 12 months. Open-label design was the principal source of potential bias. Sensitivity analysis including the wound-level trial preserved effect direction with increased heterogeneity. CONCLUSIONS: Randomized evidence demonstrates that, in early-treated debridement-eligible burns with limited total body surface area burned (TBSA), BBD reduces operative and graft burden without compromising wound closure or long-term remodeling. Future trials incorporating blinded operative endpoint adjudication, objective assessment of dermal preservation and broader clinical outcomes will further clarify treatment effect and optimize patient selection.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Sacasa F, Herdocia Baus G, Quach MP, et al. Bromelain-based enzymatic debridement versus standard of care in deep partial- and full-thickness burns: A systematic review and meta-analysis of randomized controlled trials. Burns. 2026. PMID: 42520422. doi:10.1016/j.burns.2026.108154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。